Keros Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Keros Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q2 2024.
  • Keros Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -41.1 %, a 5.47% decline year-over-year.
  • Keros Therapeutics, Inc. annual Return On Assets for 2023 was -42.6 %, a 3.85% decline from 2022.
  • Keros Therapeutics, Inc. annual Return On Assets for 2022 was -41 %, a 72.1% decline from 2021.
  • Keros Therapeutics, Inc. annual Return On Assets for 2021 was -23.8 %, a 18.8% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -41.1 -2.13 -5.47% Apr 1, 2024 Jun 30, 2024
Q1 2024 -41.7 -1.94 -4.88% Jan 1, 2024 Mar 31, 2024
Q4 2023 -42.6 -1.58 -3.85% Oct 1, 2023 Dec 31, 2023
Q3 2023 -41.5 -7.69 -22.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -38.9 -5.7 -17.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -39.8 -11.9 -42.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -41 -17.2 -72.1% Oct 1, 2022 Dec 31, 2022
Q3 2022 -33.8 -8.81 -35.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 -33.2 -9.37 -39.3% Apr 1, 2022 Jun 30, 2022
Q1 2022 -27.8 -3.63 -15% Jan 1, 2022 Mar 31, 2022
Q4 2021 -23.8 +5.5 +18.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -25 +16.6 +39.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -23.9 Apr 1, 2021 Jun 30, 2021
Q1 2021 -24.2 Jan 1, 2021 Mar 31, 2021
Q4 2020 -29.3 Oct 1, 2020 Dec 31, 2020
Q3 2020 -41.6 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.